US Healthcare Essay

Total Length: 1357 words ( 5 double-spaced pages)

Total Sources: 4

Page 1 of 5

U.S. Healthcare

The final legislation should have incorporated provisions to boost the IVD industry. On its entirety, the Patient Protection and Affordable Care Act must have benefited the IVD industry. This would have increased sales in a span of five years that it is otherwise seen in the absence of the law. Most significant IVD sales drivers will result from the legislation as an expansion of in the number of insured citizens and new coverage of prevention and wellness programs. If various key provisions are included in the PPACA, coupled with the population demographics, IVD product sales will be stimulated. This industry will die or live based on the number of the test procedures and hence increase in the number of persons with healthcare coverage will be appropriate for IVD. The Patient Protection and Affordable Care Act is a sophisticated legislature, virtually affecting all aspects of healthcare and the majority of its provisions have begun to take effect. The goal of the Act must be to increase access to healthcare coverage for legal residents and U.S. citizens by asking people to have coverage and employers to support or offer coverage (Parks, 2012). If PPACA is expanded to address issues in IVD, it will increase the number of insured U.S. individuals, product innovation, and new coverage of preventive and wellness programs. The Act should eliminate legislation, likely to generate challenges like the medical device excise tax. The legislation has not addressed a number of issues. They include public confusion about the PPACA, state expansion of Medicaid, Medicare payment rates reform and future of the medical device tax.

Q2

Confronted with a myriad of reforms in the global market place, companies in the pharma industry know that they need to change and adopt a new commercial model. Companies must adopt the best route to a new commercial model. This process includes consideration of possible pitfalls to consider. Soon, the pharmaceutical market will be commoditized globally in areas where pharmaceutical firms have heavily invested.
A shift in stakeholder influence and regulations that are more stringent is likely to contribute to further misalignments if pharma companies do not revise their commercial models. Although companies recognize the upcoming patient cliff and new they ought to be prepared, they lacked a common approach to a new commercial model (Ross & Ross, 2013).

Currently, the major industry challenges and pressures are well understood. Some customers have the implementation and development of a new commercial model on their agenda. Organizations have reported that they recognized the need for change, but they have not yet started the evolution to a new commercial model. On the contrary, a number of organizations are not even considering change. The greatest challenge in considering the change are maintaining business as usual and managing change implementation and change within the organization. While change is fundamentally on the records for most companies, it tends to be difficult to know where to start. Pharmaceutical companies are prisoners of their own success. Although the business setting for these firms has drastically changed in the recent years, the pharma commercial model, which served the industry in the previous decades, has failed to keep pace. Pharma executives are aware, and this is hardly news to them, a majority of whom doubts the viability of investments in selling capability, science and plants, which previously yielded incremental changes and restored historic returns. Leaders in the drug industry believe that massive changes to the blockbuster model are likely to rekindle old sparks and restore value. However, this strategy will only delay the inevitable. Drawing from current investment levels, forecasts of commercial performance and success rates, the blockbuster model can only be expected to deliver approximately 10% return on investment. This is substantially lower than the industry's risk cost of capital (Schweitzer, 2007).

Q3

Over the last years, the….....

Show More ⇣


     Open the full completed essay and source list


OR

     Order a one-of-a-kind custom essay on this topic


Related Essays

Healthcare Challenges in the United States

The Greatest Challenge to US Healthcare The role is played by the government The role played by the government in healthcare is a divisive issue. Many healthcare organizations executives do support the idea of extending healthcare coverage to the uninsured, however, who this is implemented is the cause of concern. There are numerous changes that are taking place in the healthcare industry and the government needs to catch up quickly. Policy development is the role of government and there is a need to ensure that there are timely and applicable policies in place to… Continue Reading...

Population Health Management

of the overall health care puzzle, rather than a replacement for treatment-based cared. Inkelas and McPherson (2015) argue that the US healthcare system, as presently designed, is ill-equipped to adopt population health management. First, it is primarily a for-profit health system, so there is incentive to run a disease treatment model – healthier populations are less profitable. Second, there is relatively little incentive for population health management when different health care providers operate in the same region, competing against each other for business. None has any incentive to engage in population health management. It is much easier to see the logic of population health management in a country like Canada,… Continue Reading...

Pros and Cons of the Affordable Care Act

that the aim of the ACA was to address “long-standing challenges facing the US healthcare system related to access, affordability, and quality of care” (525). Those three points—access, affordability and quality—were the main selling points of the ACA. The legislation was supposed to provide more access to care for people. It was supposed to make care more affordable, and it was supposed to increase the quality of care by promoting preventive medicine, as Obama noted in his article for JAMA. Critics of the ACA have stated that it actually fails in every single one of its aims: healthcare access is limited thanks to… Continue Reading...

Economy and U.S. Health Care

growth was accompanied by a concurrent sharp rise in insurance companies’ premiums. Furthermore, it led to a tremendous healthcare sector burden, increasing the nation’s budget twofold, from 1.3-2.5 trillion dollars according to 2009 estimates (Tuller, 2017). The above phenomenon constituted a gross domestic product increase of 3.8 percentage points (pps.), committed to America’s healthcare sector. In Tuller’s (2017) opinion, the healthcare structure is a “hidden thief” that may be held accountable for no appreciable rise in the wages of the average worker. Kellerman and Auerbach (2017) contend that swiftly growing healthcare expenditure may end up harming the nation’s economy by bringing about employment and GDP declines and a… Continue Reading...

Differences Between Inferential and Descriptive Statistics

US Healthcare System Healthcare staffing needs are expected to change in the next 10 years. As 78 million Americans are expected to hit retirement age, there will be need for more healthcare staffs who cater for the needs of the elderly or aging population. Garson & Levin (2001) state that changes in the healthcare sector are expected to enhance patient care processes, improved quality of care, and increased efficiency. Modern trends in the health sector shows that healthcare systems will evolve to best leverage a global market for their services… Continue Reading...

Patient with Chest Pain

ACS has been linked to significant mortality and morbidity, significantly burdening the US healthcare system financially. Its diagnosis commences with an in-depth clinical evaluation of presenting patient symptoms, cardiac troponin level, electrocardiogram, and prior medical history examination. Early stratification of risk may help providers ascertain which approach ought to be adopted: initial conservative or early invasive, besides facilitating ascertainment of appropriate pharmacologic treatments (Smith JN, 2015). ACS’s characteristic symptom include substernal chest pain, described typically as a pressing or crushing feeling, that radiates to the left arm and jaw. This doesn’t, however, manifest in all cases. Presenting symptoms may be highly subtle… Continue Reading...

Role of Depression and Medication

failure. Self-care discrepancies have been established to be considerably linked with deleterious healthcare results amongst heart failure patients. It has been conveyed that patients with heart failure who show diminished self-care capabilities in undertakings like medication compliance have recurrent hospitalizations and dwindled quality of life (Britz and Dunn, 2010). Medication adherence is a multi-faceted aspect impacted by different areas including factors associated to a certain condition, for instance, the severity of the signs and comorbidity. In this regard, depression has been demonstrated to be a fundamental factor in medication adherence. This is a progressively more worrying issue in patients with heart… Continue Reading...

sample essay writing service

Cite This Resource:

Latest APA Format (6th edition)

Copy Reference
"US Healthcare" (2013, December 09) Retrieved May 9, 2024, from
https://www.aceyourpaper.com/essays/healthcare-179323

Latest MLA Format (8th edition)

Copy Reference
"US Healthcare" 09 December 2013. Web.9 May. 2024. <
https://www.aceyourpaper.com/essays/healthcare-179323>

Latest Chicago Format (16th edition)

Copy Reference
"US Healthcare", 09 December 2013, Accessed.9 May. 2024,
https://www.aceyourpaper.com/essays/healthcare-179323